BIOAGE LABS, INC. — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-82M
Free Cash Flow
$-82M
Investing Cash Flow
$-95M
Financing Cash Flow
$11M
Capex
$719K
Stock-Based Comp
$12M
Debt Issued
—
Debt Repaid
$6M
D&A
$200K
SBC Allocated Expense
$12M